I see a red flag in the author not including any sort of bullet-point summary of concerns. If they have serious concerns, and would like clinicians and researc

I see a red flag in the author not including any sort of bullet-point summary of concerns. If they have serious concerns, and would like clinicians and researchers to take a look at them, it's not going to go too far without some sort of an abstract or brief summary table. When you structure it instead as a longform blog-post with no summary it limits the ability of busy people to quickly check into and either comment on, validate, or debunk the concerns in a systematic fashion. A set of very brief bullet points could just be emailed to Pfizer, FDA, whoever with request for comment, and those points could be quickly addressed.